Found: 9
Select item for more details and to access through your institution.
Profiling of 3D Genome Organization in Nasopharyngeal Cancer Needle Biopsy Patient Samples by a Modified Hi-C Approach.
- Published in:
- Frontiers in Genetics, 2021, v. 12, p. 1, doi. 10.3389/fgene.2021.673530
- By:
- Publication type:
- Article
Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 192, n. 1, p. 131, doi. 10.1007/s10549-021-06470-7
- By:
- Publication type:
- Article
Facilitators and barriers to medication adherence with adjuvant endocrine therapy in women with breast cancer: a structural equation modelling approach.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 3, p. 779, doi. 10.1007/s10549-021-06204-9
- By:
- Publication type:
- Article
Use of decision aid to improve informed decision-making and communication with physicians on the use of oral complementary and alternative medicine (CAM) among cancer patients on chemotherapy treatment: a randomised controlled trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Beliefs about medicines and adherence in women with breast cancer on adjuvant endocrine therapy.
- Published in:
- Journal of Health Psychology, 2022, v. 27, n. 5, p. 1111, doi. 10.1177/1359105321990776
- By:
- Publication type:
- Article
A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 6, p. 1531, doi. 10.1007/s00262-021-03075-3
- By:
- Publication type:
- Article
Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 3, p. 355, doi. 10.1007/s11523-022-00886-x
- By:
- Publication type:
- Article
Low-Dose Nivolumab in Renal Cell Carcinoma: A Real-World Experience.
- Published in:
- Oncology, 2021, v. 99, n. 3, p. 192, doi. 10.1159/000512000
- By:
- Publication type:
- Article